BioSpace News Archive

Policy

Vitality Biopharma Receives DEA Renewal for Cannabinoid Pharma Development ProgramApproval of Vitality research program and manufacturing operations through May 2019

Vitality Biopharma, Inc. announced that it has received approval from both the U.S. Drug Enforcement Administration (DEA) and the State of California Research Advisory Panel which permits the Company to continue development of its novel cannabinoid pharmaceutical prodrugs.

July 5, 2018
·
3 min read
Business

PositiveID CEO Details New Distribution Agreement with Leading Non-Invasive Patient Monitoring Technology CompanyAgreement for new Bluetooth thermometer and other topics discussed in interview with CEOLIVE.TV

PositiveID Corporation announced a new interview with Chairman and CEO William J. Caragol

July 5, 2018
·
2 min read
Drug Development

Alder BioPharmaceuticals® to Present New Data Further Highlighting Eptinezumab’s Efficacy Profile for Migraine Prevention at American Headache Society Meeting

Alder BioPharmaceuticals, Inc. announced that it will present updated data from the PROMISE 1 and PROMISE 2 phase 3 clinical trials for eptinezumab, Alder’s lead investigational product candidate for migraine prevention, at the upcoming American Headache Society (AHS) annual scientific meeting

July 5, 2018
·
12 min read
BioMidwest

Innovest Global New Corporate Website Sets Platform for Future, Highlights Value Proposition for Acquired Entities

Innovest Global Inc. replaced its longstanding corporate website

July 5, 2018
·
3 min read
Drug Development

NewLink Genetics Announces Updated Data for Indoximod Plus Radio-Immunotherapy in DIPG to be Presented at ISPNO 2018 Meeting

NewLink Genetics Corporation announced that updated data for patients with diffuse intrinsic pontine glioma (DIPG) from NLG2105, a Phase 1 study evaluating indoximod in combination with radiation and chemotherapy for the treatment of pediatric patients with progressive brain tumors, will be presented at the International Symposium on Pediatric Neuro-Oncology (ISPNO)

July 5, 2018
·
3 min read
Deals

Diamond Equity Research Initiates Coverage on Oragenics Inc. (NYSE:OGEN) with a Valuation of $3.50 Per Share

Diamond Equity Research has initiated coverage of Oragenics Inc.

July 5, 2018
·
4 min read
Business

Easton Pharmaceuticals Announces New Director / Officer to Its Board and Updates to Business Direction

Easton Pharmaceuticals Inc. is pleased to announce a new director and officer to its board with the appointment of Mr. Vince Demasi of Alliance Group, as Chief Operating Officer & Director, and updates to business direction.

July 5, 2018
·
4 min read
Deals

Novacap to expand its pharmaceutical offering in the U.S. with the acquisition of PCI Synthesis

Novacap announced that it has signed an agreement to acquire Boston-based PCI Synthesis

July 5, 2018
·
4 min read
Policy

Smoke Cartel Moves into E-liquid and Nicotine Sales and Enlists BlueCheck for FDA Age Compliance

Smoke Cartel, Inc. announced they have enlisted the services of BlueCheck, an age and identity verification company for tobacco and vapor products.

July 5, 2018
·
3 min read
Deals

Savaria Declares its Monthly Dividend

Savaria Corporation declared on June 20th a dividend of 3 cents ($0.03) per common share

July 5, 2018
·
1 min read